Minara's doing pretty well considering the capital return knocked the SP around a bit. It looks like the cap on SP won't last long- it's a very desirable stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025